The Pilot Bioproduction Facility's (PBF) mission is research, development, production, and testing of vaccines for human use. The PBF at Forest Glen is a multi-use facility
designed and operated for production of vaccines in compliance with current Good Manufacturing Practice (cGMP) regulations.
Compliance with cGMP ensures that products prepared in this facility will be safe, potent, and reproducible.
Vaccines are produced that will protect Soldiers against diseases they may encounter in areas of deployment.
These products include vaccines to prevent shigellosis and other diarrheal infections, dengue, malaria, meningitis, and HIV.
The Pilot Bioproduction Facility (PBF) offers manufacturing of clinical grade material for clients in the public and private sectors through
cooperative research and development agreements. Since 1958 as the Department of Biologics Research, the PBF has specialized in developing vaccines
for DoD mission-related disease threats, especially infectious diseases, by following all federal regulations which apply to biological products.
The PBF guarantees quality assurance during the en
tire process of vaccine development- compliance, cleanliness, and safety are top priorities.
Experienced staff and modern equipment assure the integrity of vaccines. Classified-air cleanrooms are used for seed preparation,
fermentation, purification, and filling.